
Tilray Brands (TLRY) Stock
Diversified cannabis and consumer products company operating globally. Here's the price, business snapshot, and what's worth knowing about Tilray Brands in October 2026.
Tilray Brands, Inc (TLRY) is a diversified cannabis and consumer products company formed after the Aphria merger; it cultivates, manufactures and distributes medical and adult‑use cannabis, hemp‑derived CBD products and ancillary consumer goods across several international markets. The business mixes consumer packaged goods—under retail brands and beverage partnerships—with wholesale and medical cannabis operations, aiming to scale through brand building and cost efficiencies. With a market capitalisation around $1.66bn, Tilray is still navigating profitability and margin improvement while pursuing growth in jurisdictions where regulation allows. Key considerations for investors include regulatory uncertainty, capital intensity, inventory and pricing pressures, and commodity‑like volatility in the cannabis sector. Because the stock can be volatile and the industry remains shaped by evolving laws and competition, this summary is general educational information only and not personalised advice. Stocks can fall as well as rise; consider your risk tolerance and seek independent financial advice if needed.
Tilray Brands (TLRY) Stock Forecast
Analyst price target, next 12 months
$4.17
+17.9% vs today's $3.54
Price range over the last 12 months
Close to its 12-month low
Analysts covering Tilray Brands have a consensus 12-month target of $4.17, above the current price of $3.54.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 12 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Tilray's stock with a target price of $4.17, indicating possible future growth.
Financial Health
Tilray Brands is generating decent revenue and cash flow, but profitability remains a concern.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Growth and Scale
Tilray is building brands and distribution globally, which could support revenue growth, though execution and margin improvement are not guaranteed.
Regulatory Impact
Changes in cannabis laws and licensing shape Tilray's addressable markets; regulatory shifts can create opportunity but also add uncertainty.
International Footprint
A diversified presence across markets spreads exposure beyond one geography, yet cross‑border rules and local competition add complexity and risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.